{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:08Z","timestamp":1787020748011,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1051-3","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:03:11Z","timestamp":1554278591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-5315","authenticated-orcid":false,"given":"Carl Michael","family":"Baravelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasne Karine","family":"Aarsand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Christophersen","family":"Toll\u00e5nes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bpg.2010.07.002","volume":"24","author":"J Frank","year":"2010","unstructured":"Frank J, Poblete-Gutierrez P. Porphyria cutanea tarda--when skin meets liver. Best Pract Res Clin Gastroenterol. 2010;24:735\u201345.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4045\/tidsskr.13.0649","volume":"134","author":"M Mykletun","year":"2014","unstructured":"Mykletun M, Aarsand AK, Stole E, Villanger JH, Tollanes MC, Baravelli C, et al. Porphyrias in Norway. Tidsskr Nor Laegeforen. 2014;134:831\u20136.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1051_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1373\/clinchem.2008.117432","volume":"55","author":"AK Aarsand","year":"2009","unstructured":"Aarsand AK, Boman H, Sandberg S. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clin Chem. 2009;55:795\u2013803.","journal-title":"Clin Chem"},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0738-081X(99)00029-2","volume":"17","author":"GH Elder","year":"1999","unstructured":"Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol. 1999;17:431\u20136.","journal-title":"Clin Dermatol"},{"key":"1051_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0168-8278(03)00399-4","volume":"39","author":"S Fargion","year":"2003","unstructured":"Fargion S, Fracanzani AL. Prevalence of hepatitis C virus infection in porphyria cutanea tarda. J Hepatol. 2003;39:635\u20138.","journal-title":"J Hepatol"},{"key":"1051_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/00015550510033688","volume":"85","author":"I Rossmann-Ringdahl","year":"2005","unstructured":"Rossmann-Ringdahl I, Olsson R. Porphyria cutanea tarda in a Swedish population: risk factors and complications. Acta Derm Venereol. 2005;85:337\u201341.","journal-title":"Acta Derm Venereol"},{"key":"1051_CR7","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1111\/j.1600-0625.2009.01040.x","volume":"19","author":"A Fontanellas","year":"2010","unstructured":"Fontanellas A, Martinez-Fresno M, Garrido-Astray MC, Perucho T, Moran-Jimenez MJ, Garcia-Bravo M, et al. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda. Exp Dermatol. 2010;19:e326\u20138.","journal-title":"Exp Dermatol"},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MD.0b013e3181d50928","volume":"89","author":"C Munoz-Santos","year":"2010","unstructured":"Munoz-Santos C, Guilabert A, Moreno N, To-Figueras J, Badenas C, Darwich E, et al. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore). 2010;89:69\u201374.","journal-title":"Medicine (Baltimore)"},{"key":"1051_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0676.1992.tb00557.x","volume":"12","author":"PD Siersema","year":"1992","unstructured":"Siersema PD, ten Kate FJ, Mulder PG, Wilson JH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver. 1992;12:56\u201361.","journal-title":"Liver."},{"key":"1051_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/01.meg.0000108318.52416.c9","volume":"16","author":"JP Gisbert","year":"2004","unstructured":"Gisbert JP, Garcia-Buey L, Alonso A, Rubio S, Hernandez A, Pajares JM, et al. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda. Eur J Gastroenterol Hepatol. 2004;16:689\u201392.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1051_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0168-8278(01)00160-X","volume":"35","author":"AL Fracanzani","year":"2001","unstructured":"Fracanzani AL, Taioli E, Sampietro M, Fatta E, Bertelli C, Fiorelli G, et al. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol. 2001;35:498\u2013503.","journal-title":"J Hepatol"},{"key":"1051_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/oxfordjournals.aje.a009745","volume":"149","author":"MS Linet","year":"1999","unstructured":"Linet MS, Gridley G, Nyren O, Mellemkjaer L, Olsen JH, Keehn S, et al. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol. 1999;149:1010\u20135.","journal-title":"Am J Epidemiol"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264\u201373 e1.","journal-title":"Gastroenterology."},{"key":"1051_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.gastro.2004.09.020","volume":"127","author":"TR Morgan","year":"2004","unstructured":"Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127:87\u201396.","journal-title":"Gastroenterology."},{"key":"1051_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/joim.12646","volume":"282","author":"CM Baravelli","year":"2017","unstructured":"Baravelli CM, Sandberg S, Aarsand AK, Nilsen RM, Tollanes MC. Acute hepatic porphyria and cancer risk: a nationwide cohort study. J Intern Med. 2017;282:229\u201340.","journal-title":"J Intern Med"},{"key":"1051_CR16","volume-title":"Norsk porfyriregister","author":"Nasjonalt servicemilj\u00f8 for medisinske kvalitetsregistre","year":"2012","unstructured":"Nasjonalt servicemilj\u00f8 for medisinske kvalitetsregistre. Norsk porfyriregister. 2012 \n                    https:\/\/www.kvalitetsregistre.no\/registers\/norsk-porfyriregister\n                    \n                  . Accessed 23 May 2016."},{"key":"1051_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45:1218\u201331.","journal-title":"Eur J Cancer"},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.4045\/tidsskr.14.1065","volume":"135","author":"AG Pedersen","year":"2015","unstructured":"Pedersen AG, Ellingsen CL. Data quality in the causes of death registry. Tidsskr Nor Laegeforen. 2015;135:768\u201370.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1051_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/B978-1-4160-6164-9.00033-0","volume-title":"Tietz textbook of clinical chemistry and molecular diagnostics","author":"M Badminton","year":"2012","unstructured":"Badminton M, Deacon A, Elder G. The porphyrias and other disorders of porphyrin metabolism. In: Burtis C, Aashwood E, Bruns D, editors. Tietz textbook of clinical chemistry and molecular diagnostics. St. Louis: Elsevier Saunders; 2012. p. 1031\u201352."},{"key":"1051_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"1051_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593\u2013608.","journal-title":"J Hepatol"},{"key":"1051_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/00365520310004542","volume":"38","author":"O Dalgard","year":"2003","unstructured":"Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol. 2003;38:864\u201370.","journal-title":"Scand J Gastroenterol"},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2334-11-153","volume":"11","author":"G Rimseliene","year":"2011","unstructured":"Rimseliene G, Nilsen O, Klovstad H, Blystad H, Aavitsland P. Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis. 2011;11:153.","journal-title":"BMC Infect Dis"},{"key":"1051_CR24","first-page":"200","volume":"18","author":"M Sokmen","year":"2007","unstructured":"Sokmen M, Demirsoy H, Ersoy O, Gokdemir G, Akbayir N, Karaca C, et al. Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: case report. Turk J Gastroenterol. 2007;18:200\u20135.","journal-title":"Turk J Gastroenterol"},{"key":"1051_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dar.12810","volume":"37","author":"T Huckle","year":"2018","unstructured":"Huckle T, Romeo JS, Wall M, Callinan S, Holmes J, Meier P, et al. Socio-economic disadvantage is associated with heavier drinking in high but not middle-income countries participating in the international alcohol control (IAC) study. Drug Alcohol Rev. 2018;37:63\u201371.","journal-title":"Drug Alcohol Rev"},{"key":"1051_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/ije\/dyy131","volume":"47","author":"SH Gage","year":"2018","unstructured":"Gage SH, Bowden J, Davey Smith G, Munafo MR. Investigating causality in associations between education and smoking: a two-sample Mendelian randomization study. Int J Epidemiol. 2018;47:1131\u201340.","journal-title":"Int J Epidemiol"},{"key":"1051_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1039\/C8TX00019K","volume":"7","author":"AG Smith","year":"2018","unstructured":"Smith AG, Foster JR. The association between chemical-induced porphyria and hepatic cancer. Toxicol Res (Camb). 2018;7:647\u201363.","journal-title":"Toxicol Res (Camb)"},{"key":"1051_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0781.1997.tb00116.x","volume":"13","author":"HW Lim","year":"1997","unstructured":"Lim HW. Role of viral infection in porphyria cutanea tarda. Photodermatol Photoimmunol Photomed. 1997;13:75\u20137.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1051_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejca.2011.12.021","volume":"48","author":"European Association for Study of Liver; European Organisation for Research and Treatment of Cancer","year":"2012","unstructured":"European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599\u2013641.","journal-title":"Eur J Cancer"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1051-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:19:45Z","timestamp":1585768785000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1051-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1051-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Regional Committees for Medical and Health Research Ethics, Norway (reference number: 2012\/753).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"77"}}